Correction to Novartis Eye-Disease Drug Article on Tuesday

Date : 10/10/2019 @ 04:38
Source : Dow Jones News
Stock : Novartis AG (NVS)
Quote : 86.56  -0.32 (-0.37%) @ 07:40
Novartis share price Chart
After Hours
Last Trade
Last $ 86.56 ◊ 0.00 (0.00%)

Correction to Novartis Eye-Disease Drug Article on Tuesday

Novartis (NYSE:NVS)
Historical Stock Chart

1 Month : From Sep 2019 to Oct 2019

Click Here for more Novartis Charts.

Beovu showed it was non-inferior in terms of improvements in visual acuity for patients compared with rival treatment aflibercept. "Novartis Sees Blockbuster Potential in Eye-Disease Drug -- Update," on Oct. 8 at GMT 1216, misstated that Beovu achieved superior visual improvements compared with aflibercept in the fifth paragraph. The error also appeared in an earlier version of the story, "Novartis: US FDA Approves Eye-Disease Treatment Beovu," at 0535 GMT the same day.

 

(END) Dow Jones Newswires

October 09, 2019 13:23 ET (17:23 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Your Recent History
FX
EURAUD
Euro vs Au..
FX
USDAUD
US Dollar ..
ASX
WPL
Woodside
NASDAQ
AAPL
Apple
ASX
BHP
BHP Bilito..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20191021 21:32:15